GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) and the dual GLP-1/GIP drug tirzepatide (Mounjaro/Zepbound) work by mimicking gut hormones that slow digestion, blunt appetite, and improve how your body handles blood sugar
The life elixir and the fountain of youth
For a deeper ingredient overview, read: What Is GHK-Cu
BENEFITS Combined mechanism studied for complementary tissue-repair pathways in a single formulation Convenience eliminates the need to source and reconstitute two separate vials Recovery research explored for combined effects on connective tissue and muscle models Anti-inflammatory linked to dual anti-inflammatory pathways from both compounds Wound healing associated with accelerated recovery timelines in preclinical models WHAT RESEARCHERS LOOK AT Synergistic vs additive effects of BPC-157 and TB-500 co-administration Angiogenesis promotion from the dual-peptide combination Comparative recovery timelines: blend vs individual compounds Optimal dosing ratios in combined formulations Fibroblast migration and collagen deposition from dual pathways QUICK SPECS Form: Lyophilized peptide blend Net per vial: 10 mg total (BPC-157 5mg + TB-500 5mg) Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS Components: BPC-157 (CAS 137525-51-0) + TB-500 (CAS 77591-33-4) Blend ratio: 1:1 (5mg each) WHY CHOOSE DURHAM PEPTIDES FOR THE WOLVERINE STACK
To view a copy of this licence, visit About this article Cite this article Matthews, E.C., Carter, A.L., Pathak, P
Our CJC-1295 Without DAC research guide covers GHRH receptor activation as the upstream stimulus for GH secretion, providing important context for understanding where AOD-9604 sits within the broader GH signalling research framework
